Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Intangibles (2019 - 2025)

Silo Pharma (SILO) has disclosed Intangibles for 3 consecutive years, with $217375.0 as the latest value for Q4 2025.

  • Quarterly Intangibles fell 9.88% to $217375.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $217375.0 through Dec 2025, down 9.88% year-over-year, with the annual reading at $217375.0 for FY2025, 9.88% down from the prior year.
  • Intangibles hit $217375.0 in Q4 2025 for Silo Pharma, down from $235000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $247400.0 in Q2 2024 to a low of $217375.0 in Q4 2025.